|
Type | Source | Type of activity | References |
|
Fucoxanthin | U. pinnatifida | Inhibitory effect against growth of GOTO cells, a human neuroblastoma cell line | [46] |
Fucoxanthin | U. pinnatifida | Inhibitory effect against duodenal carcinogenesis induced by N-ethyl-N′-nitro-N-nitrosoguanidine in mice | [47] |
Fucoxanthin | U. pinnatifida | Suppression of skin and liver carcinogenesis in vivo | [48] |
Fucoxanthin | H. fusiforme | Reduced development of putative preneoplastic aberrant crypt foci (ACF) in colon of mice | [49] |
Fucoxanthin | U. pinnatifida | Inhibitory effect against the proliferation of HL-60, human leukemia cell line, through apoptosis | [50] |
Fucoxanthin | U. pinnatifida | Decreased cell viability in prostate cancer cell lines of PC-3, DU 145, and LNCaP | [51] |
Fucoxanthin | U. pinnatifida | Inhibitory effect against viability of human colon cancer cell lines, HT-29, DLD-1, and Caco-2, through apoptosis | [53] |
Fucoxanthinol, amarouciaxanthin A | Metabolites of fucoxanthin | Inhibitory effect against PC-3, prostate cancer cell line | [13] |
Fucoxanthin | U. pinnatifida | Inhibitory effect against HCT116, human colorectal adenocarcinoma | [54] |
Fucoxanthin | U. pinnatifida | Induction of apoptosis in PC-3 cells via caspase-3 activation | [52] |
Fucoxanthin | L. japonica | Cell cycle arrest at G0/G1 phase in human colon cancer cells induced by upregulation of p21WAF1/Cip1 | [44] |
Fucoxanthin | Unmentioned | Induction of G1 arrest and GADD45A gene expression in HepG2 and DU145 cells | [55] |
Fucoxanthin | U. pinnatifida | Antiadult T-cell leukemia activity | [45] |
Fucoxanthinol | Metabolites of fucoxanthin | In vivo and in vitro antiadult T-cell leukemia activity | [45] |
Fucoxanthinol | L. japonica | Inhibitory effect against HepG2, human hepatic carcinoma, associated with downregulation of cyclin D | [56] |
Fucoxanthin | U. pinnatifida | Induction of cell cycle arrest in G2/M phase and apoptosis in MGC-803 cells, human gastric adenocarcinoma | [58] |
|